Bendell, J., Ciardiello, F., Tabernero, J., Tebbutt, N., Eng, C., Di Bartolomeo, M., Falcone, A., Fakih, M., Kozloff, M., Segal, N., Sobrero, A., Shi, Y., Roberts, L., Yan, Y., Chang, I., Uyei, A., & Kim, T. (n.d.). lBA-004Efficacy and safety results from IMblaze370, a randomised Phase III study comparing atezolizumab+cobimetinib and atezolizumab monotherapy vs regorafenib in chemotherapy-refractory metastatic colorectal cancer. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095512627.0x000038